Device recall: Sensi Disc Amoxicillin with Clavulanic Acid 20/10 g, Catalog No. 231628 and 231629. These discs are used for…
Class II FDA enforcement event 93789. Recall start date: . Status in the FDA record: Ongoing.
Reason for recall, in the words of FDA
There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
Class II, in the words of FDA
a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Becton Dickinson & Co. started this device recall on 8 Jan 2024. The firm address in the FDA record is in Sparks, MD. FDA put the recall in Class II. FDA event 93789 has 30 product records. The first FDA enforcement report date is 14 Feb 2024. The record gives the status Ongoing.
It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.
FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .
Distribution
In the words of FDA.
Domestic distribution nationwide. International distribution worldwide.
Recalling firm
Becton Dickinson & Co., Sparks, MD.
Recalling firm: The firm that the FDA record names for a recall.
FDA records how the recall started: Voluntary: Firm initiated.
Products
30 product records in the event.
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| Z-1011-2024 | Sensi Disc Amoxicillin with Clavulanic Acid 20/10 g, Catalog No. 231628 and 231629. These discs are used for semi-quantitative in vitro susceptibility testing | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1012-2024 | BD BBL Sensi Disc Ampicillin - 10 g, Catalog No. 230705 and 231264; 2 g, Catalog No. 231263. Used for semi-quantitative in vitro susceptibility testing. | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1013-2024 | BD BBL Sensi Disc Ampicillin with Sulbactam 10/10 g, Catalog Number 231660. Used for semi-quantitative in vitro susceptibility testing. | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1014-2024 | BD BBL Sensi Disc Augmentin - 3¿g, Catalog Number 291270¿used for semi-quantitative in vitro susceptibility testing. | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1015-2024 | BD BBL Sensi Disc Azithromycin -15 g, Catalog Number 231682¿used for semi-quantitative in vitro susceptibility testing. | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1016-2024 | BD BBL Sensi Disc Aztreonam - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Numbers 231640¿and 231641. | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1017-2024 | BD BBL Sensi Disc Cefaclor - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231653¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1018-2024 | BD BBL Sensi Disc Cefepime - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231696¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1019-2024 | BD BBL Sensi Disc Cefixime - 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231664¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1020-2024 | BD BBL Sensi Disc Cefotaxime - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231606 and 231607¿; 5 ug, Catalog No. 291308¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1021-2024 | BD BBL Sensi Disc Cefpodoxime - 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231673 and 231674¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1022-2024 | BD BBL Sensi Disc Ceftaroline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232231¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1023-2024 | BD BBL Sensi Disc Ceftazidime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231632¿and 231633¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1024-2024 | BD BBL Sensi Disc Ceftriaxone- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231634 and 231635¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1025-2024 | BD BBL Sensi Disc Cefuroxime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231621¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1026-2024 | BD BBL Sensi Disc Chloramphenicol- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 230733¿and 231274¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1027-2024 | BD BBL Sensi Disc Ciprofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231657¿and 231658¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1028-2024 | BD BBL Sensi Disc Clarithromycin- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231678¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1029-2024 | BD BBL Sensi Disc Doripenem- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232219¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1030-2024 | BD BBL Sensi Disc Ertapenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232174 and 232175¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1031-2024 | BD BBL Sensi Disc Imipenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231644 and 231645¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1032-2024 | BD BBL Sensi Disc Levofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231705 and 231706¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1033-2024 | BD BBL Sensi Disc Meropenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231703 and 231704¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1034-2024 | BD BBL Sensi Disc Minocycline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231250 and 231251¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1035-2024 | BD BBL Sensi Disc Moxifloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231758¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1036-2024 | BD BBL Sensi Disc Ofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231672¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1037-2024 | BD BBL Sensi Disc Piperacillin/Tazobactam- 100/10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231691 and 231692¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1038-2024 | BD BBL Sensi Disc Rifampin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231541 and 231544¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1039-2024 | BD BBL Sensi Disc Sulfamethoxazole with Trimethoprim 23.75/1.25 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231536 and 231539¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
| Z-1040-2024 | BD BBL Sensi Disc Tetracycline 30 ug,used for semi-quantitative in vitro susceptibility testing. Catalog Number 230998 and 231344¿ | 2,363,168 total units | Class II | Ongoing | 14 Feb 2024 |
openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.
Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.
Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.
Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.
Class II: The middle of the three FDA recall classes.
The event in context
- Device events that started in 2024
- 970
- Share of these events in Class II
- 87%
- Product records in this event
- 30Median of the firm: 1
- Events of the firm on the register
- 77
Other events of the firm
Official channels
- FDA enforcement report Z-1011-2024The FDA record of the first product of this event.
- FDA: recalls, market withdrawals and safety alertsThe recall notices on the FDA site.
- FDA MedWatchThe FDA safety reporting program for drugs and medical devices.
Follow by RSS:Food, drug and device recallsFDA Class I recalls
Cite this page
Recall Register. FDA enforcement event 93789. https://recallregister.com/fda/ii/93789/. Source: openFDA enforcement reports. Data through .
Sources
- Source
- openFDA device enforcement reports
- Licence
- CC0 1.0
- Export date
- 28 Sep 2026
- Newest FDA report date on the register
- 23 Sep 2026
FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.
Questions
- Where was the product distributed?
- The FDA record gives this distribution:
Domestic distribution nationwide. International distribution worldwide.
- What quantity of product is in FDA event 93789?
- The event has 30 product records. The first record gives this quantity:
2,363,168 total units
- How did the recall start?
- The FDA record says:
Voluntary: Firm initiated
- How many device recalls of 2024 have the same class?
- 87% of the 970 device events that started in 2024 are in Class II.